Demonstrating Value to Venture Capitalists to Secure Investment for Intranasal Drug Development
Time: 11:30 am
day: Day 1
Details:
- Examine investor due diligence with patient advocacy
- Best practices for investors to understand the relationship between advocacy organizations and KOLs
- Understanding the role that these different groups play in the valuation of new products
